tetano
Editor, Senior Moderator
In the Medical Centers Doctor Stamboulian they appealed to an unpublished resource: to apply to him the anti-flu trivalent vaccine (it contains the pandemic vine-stock H1N1 or Flu To and the seasonal ones) it is necessary to mark shift previous. It is possible to extract it only by phone, but the telephone lines of the vacunatorio are completely colapsadas due to the " extraordinary demand " that are having these medicines. And this demand would be far from remaining satisfied: in the proper laboratories they already glimpse that in the Argentina there will be available less vaccines against the flu that in other years and that those who will not reach beech for all. To prepare a possible epidemic of Flu To, at the end of February a national campaign was thrown to vaccinate of free form children younger than 5 years, pregnant women, workpeople of the health and those who are in the groups of risk (obese, diabetic, transplanted and asthmatic, between others).
This vaccine, which it foresees to apply in 10.800.000 persons, is monovalente, that is to say only it serves against the Flu A. " The important thing was to prepare the population that more complications and mortality had last year against this vine-stock ", told Carla Vizotti, chief of the National Program of Immunization of the Department of Health.
Like that, any that wants to be vaccinated to if the same or to his children and it is not reached by the national campaign will have to choose to be vaccinated of private form, any time he could pay the dose. Also there should choose this option those that prefer applying to themselves a trivalent vaccine instead of a monovalente. The virus that more will circulate this winter is that of the Flu To, but also it is hoped that there should propagate that of the seasonal influenza. Till now there went out to the selling only the bovine trivalent Begrivac (the factory the laboratory Novartis and it sells at 71,22 weight) and Influvac (it is of Raffo and is commercialized to 71,32 weight). Both are imported. Sources of the industry thought that of the first one approximately 200.000 doses were brought and of other one next to 300.000. In Raffo they recognized to Clarion: " There came to us less doses for than we had asked the manufacturer in Holland and it did not reach us to satisfy all the clients. Of having already brought half a million we would have sold " .Sanofi Pasteur it was historically the laboratory leader in selling of vaccines against the flu, but none of his 5 authorized marks is still to the selling.
Although the laboratory affirmed to Clarion that his vaccines will come " in the middle of April ", other sources assured that that will happen newly in the middle of May and that it will bring about 500.000 doses. The ANMAT also authorized the selling of another trivalent (Nilgrip), about that it is said 200.000 doses would be imported.
Sanofi Pasteur was historically the laboratory leader in selling of vaccines against the flu, but none of his 5 authorized marks is still to the selling. Although the laboratory affirmed to Clarion that his vaccines will come " in the middle of April ", other sources assured that that will happen newly in the middle of May and that it will bring about 500.000 doses. The ANMAT also authorized the selling of another trivalent (Nilgrip), about that it is said 200.000 doses would be imported.
Revising. To the selling 500.000 of dose went out already average and other 700.000 would be imported more, with what in whole 1.200.000 vaccines would go out to the selling. But on the Argentine market about 1.300.000 doses were selling regularly. This way, this year the medicine would not reach even for those who vaccinate every autumn. And if there is risk of epidemic it is supposed that more people will think about how to vaccinate. One advises to apply the vaccine at the beginning of the autumn. The problem of fund is that the pharmaceutical industry interrupted the production of trivalent to prepare monovalentes, that were those who were needed from more urgent form. Newly later it turned to the manufacture of trivalent. " There are no the trivalent ones on the Argentine market because there is not in the world. It is a critical input ", told doctor Vizotti. " In the whole Latin America they are losing hope: they all want to buy the vaccine ", there coincided Abel Di Gilio, manager of Sinergium Biotech, the laboratory consortium that in 5 years will start producing anti-flu vaccines in the country. The strong demand is already evident in the whole chain.
In a drug store leader they counted: " We receive less dose and we had to rationalize them between all our clients ". " The demand of trivalent is tremendous: every day they call me parents to ask me that they should be prescribed to his children ", told the pediatrician Marcelo Armadans. " My advice is that the one that has to give it to him gives it to him already: when the first cases of flu are seen all together are going to to go to apply it to him and the system goes to colapsar ", he added. The infect?logo Marcelo Blumenfeld raised: " As soon as possible one applies it to him it is better. It is not like other years as which the virus starts circulating in the certain week of the autumn. The Flu To sigui? circulating during the whole summer ". The vaccine started happening yesterday in the centers Stamboulian. Also it is available in other vacunatorios and in some pharmacies.
http://www.clarin.com/diario/2010/04/01/um/m-02171773.htm
This vaccine, which it foresees to apply in 10.800.000 persons, is monovalente, that is to say only it serves against the Flu A. " The important thing was to prepare the population that more complications and mortality had last year against this vine-stock ", told Carla Vizotti, chief of the National Program of Immunization of the Department of Health.
Like that, any that wants to be vaccinated to if the same or to his children and it is not reached by the national campaign will have to choose to be vaccinated of private form, any time he could pay the dose. Also there should choose this option those that prefer applying to themselves a trivalent vaccine instead of a monovalente. The virus that more will circulate this winter is that of the Flu To, but also it is hoped that there should propagate that of the seasonal influenza. Till now there went out to the selling only the bovine trivalent Begrivac (the factory the laboratory Novartis and it sells at 71,22 weight) and Influvac (it is of Raffo and is commercialized to 71,32 weight). Both are imported. Sources of the industry thought that of the first one approximately 200.000 doses were brought and of other one next to 300.000. In Raffo they recognized to Clarion: " There came to us less doses for than we had asked the manufacturer in Holland and it did not reach us to satisfy all the clients. Of having already brought half a million we would have sold " .Sanofi Pasteur it was historically the laboratory leader in selling of vaccines against the flu, but none of his 5 authorized marks is still to the selling.
Although the laboratory affirmed to Clarion that his vaccines will come " in the middle of April ", other sources assured that that will happen newly in the middle of May and that it will bring about 500.000 doses. The ANMAT also authorized the selling of another trivalent (Nilgrip), about that it is said 200.000 doses would be imported.
Sanofi Pasteur was historically the laboratory leader in selling of vaccines against the flu, but none of his 5 authorized marks is still to the selling. Although the laboratory affirmed to Clarion that his vaccines will come " in the middle of April ", other sources assured that that will happen newly in the middle of May and that it will bring about 500.000 doses. The ANMAT also authorized the selling of another trivalent (Nilgrip), about that it is said 200.000 doses would be imported.
Revising. To the selling 500.000 of dose went out already average and other 700.000 would be imported more, with what in whole 1.200.000 vaccines would go out to the selling. But on the Argentine market about 1.300.000 doses were selling regularly. This way, this year the medicine would not reach even for those who vaccinate every autumn. And if there is risk of epidemic it is supposed that more people will think about how to vaccinate. One advises to apply the vaccine at the beginning of the autumn. The problem of fund is that the pharmaceutical industry interrupted the production of trivalent to prepare monovalentes, that were those who were needed from more urgent form. Newly later it turned to the manufacture of trivalent. " There are no the trivalent ones on the Argentine market because there is not in the world. It is a critical input ", told doctor Vizotti. " In the whole Latin America they are losing hope: they all want to buy the vaccine ", there coincided Abel Di Gilio, manager of Sinergium Biotech, the laboratory consortium that in 5 years will start producing anti-flu vaccines in the country. The strong demand is already evident in the whole chain.
In a drug store leader they counted: " We receive less dose and we had to rationalize them between all our clients ". " The demand of trivalent is tremendous: every day they call me parents to ask me that they should be prescribed to his children ", told the pediatrician Marcelo Armadans. " My advice is that the one that has to give it to him gives it to him already: when the first cases of flu are seen all together are going to to go to apply it to him and the system goes to colapsar ", he added. The infect?logo Marcelo Blumenfeld raised: " As soon as possible one applies it to him it is better. It is not like other years as which the virus starts circulating in the certain week of the autumn. The Flu To sigui? circulating during the whole summer ". The vaccine started happening yesterday in the centers Stamboulian. Also it is available in other vacunatorios and in some pharmacies.
http://www.clarin.com/diario/2010/04/01/um/m-02171773.htm